ATE410149T1 - Komprimierte, orale pharmazeutische dosierungsform mit enterischer beschichtung, die eine säurelabile benzimidazolverbindung enthält - Google Patents

Komprimierte, orale pharmazeutische dosierungsform mit enterischer beschichtung, die eine säurelabile benzimidazolverbindung enthält

Info

Publication number
ATE410149T1
ATE410149T1 AT02785447T AT02785447T ATE410149T1 AT E410149 T1 ATE410149 T1 AT E410149T1 AT 02785447 T AT02785447 T AT 02785447T AT 02785447 T AT02785447 T AT 02785447T AT E410149 T1 ATE410149 T1 AT E410149T1
Authority
AT
Austria
Prior art keywords
dosage form
pharmaceutical dosage
compressed
enteric coating
benzimidazole compound
Prior art date
Application number
AT02785447T
Other languages
English (en)
Inventor
Garcia Javier Lizcano
Perez Jaume Sangra
Ibarra Pere Joan Solanas
Cabrera Antonio Lopez
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Application granted granted Critical
Publication of ATE410149T1 publication Critical patent/ATE410149T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT02785447T 2001-12-18 2002-11-18 Komprimierte, orale pharmazeutische dosierungsform mit enterischer beschichtung, die eine säurelabile benzimidazolverbindung enthält ATE410149T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200102820A ES2198195B1 (es) 2001-12-18 2001-12-18 Forma de dosificacion farmaceutica oral comprimida, con recubrimiento enterico, que contiene un compuesto de bencimidazol labil en medio acido.

Publications (1)

Publication Number Publication Date
ATE410149T1 true ATE410149T1 (de) 2008-10-15

Family

ID=8499777

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02785447T ATE410149T1 (de) 2001-12-18 2002-11-18 Komprimierte, orale pharmazeutische dosierungsform mit enterischer beschichtung, die eine säurelabile benzimidazolverbindung enthält

Country Status (19)

Country Link
US (1) US7217429B2 (de)
EP (1) EP1464331B9 (de)
JP (1) JP4523278B2 (de)
KR (1) KR100877649B1 (de)
AT (1) ATE410149T1 (de)
AU (1) AU2002350750B2 (de)
CA (1) CA2470609C (de)
DE (1) DE60229295D1 (de)
DK (1) DK1464331T3 (de)
ES (2) ES2198195B1 (de)
HR (1) HRP20040596A2 (de)
HU (1) HUP0402488A3 (de)
IL (2) IL162544A0 (de)
MX (1) MXPA04005902A (de)
NO (1) NO20042630L (de)
NZ (1) NZ533886A (de)
PT (1) PT1464331E (de)
WO (1) WO2003051342A1 (de)
ZA (1) ZA200405078B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI372066B (en) * 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
ES2278511B1 (es) * 2005-07-28 2008-06-16 Laboratorios Almirall S.A. Comprimidos con perfil de disolucion mejorado.
WO2007100984A2 (en) * 2006-02-24 2007-09-07 Allergan, Inc. Beads containing pyridin-sulfinyl benzoimidazole sulfonyl phenoxy acetate derivatives
WO2010078541A1 (en) * 2009-01-05 2010-07-08 Mcneil-Ppc, Inc. Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen
WO2010078543A1 (en) * 2009-01-05 2010-07-08 Mcneil-Ppc, Inc. Tablet containing cetirizine pseudoephedrine, and naproxen containing a barrier layer
WO2010078542A1 (en) * 2009-01-05 2010-07-08 Mcneil-Ppc, Inc. Three layer tablet containing cetirizine, pseudoephedrine, and naproxen
WO2010117756A2 (en) * 2009-03-31 2010-10-14 Dr. Reddy's Laboratories Ltd Substituted benzimidazole pharmaceutical formulations
EP2345408A3 (de) * 2010-01-08 2012-02-29 Dr. Reddy's Laboratories Ltd. Säurelabile Arzneimittelformulierungen
NZ607225A (en) * 2010-07-22 2015-02-27 Lupin Ltd Multiple unit tablet composition
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
EP3288556A4 (de) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Oral zerfallende zusammensetzungen
WO2017145146A1 (en) 2016-02-25 2017-08-31 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189699A (en) 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
PT1078628E (pt) * 1994-07-08 2009-01-27 Astrazeneca Ab Forma de dosagem em comprimidos com unidades múltiplas
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
ES2094694B1 (es) 1995-02-01 1997-12-16 Esteve Quimica Sa Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
ES2236628T3 (es) * 1995-09-21 2005-07-16 Pharma Pass Ii Llc Composicion farmaceutica que contiene un omeprazol labil de acido, y procedimiento para su preparacion.
SE9600070D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
SE9700885D0 (sv) * 1997-03-12 1997-03-12 Astra Ab New pharmaceutical formulation
ES2168043B1 (es) * 1999-09-13 2003-04-01 Esteve Labor Dr Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
JP2002363080A (ja) * 2001-06-08 2002-12-18 Towa Yakuhin Kk 安定な内服用抗潰瘍製剤の製造法

Also Published As

Publication number Publication date
JP4523278B2 (ja) 2010-08-11
JP2005523884A (ja) 2005-08-11
IL162544A (en) 2010-04-29
DE60229295D1 (de) 2008-11-20
IL162544A0 (en) 2005-11-20
DK1464331T3 (da) 2009-01-05
PT1464331E (pt) 2008-11-19
US20030118650A1 (en) 2003-06-26
HUP0402488A2 (hu) 2005-05-30
CA2470609A1 (en) 2003-06-26
WO2003051342A1 (es) 2003-06-26
ES2198195B1 (es) 2004-10-01
ES2198195A1 (es) 2004-01-16
HUP0402488A3 (en) 2009-09-28
EP1464331B1 (de) 2008-10-08
MXPA04005902A (es) 2004-09-13
KR20040079906A (ko) 2004-09-16
ZA200405078B (en) 2005-06-27
HRP20040596A2 (en) 2004-10-31
AU2002350750A1 (en) 2003-06-30
AU2002350750B2 (en) 2008-10-16
CA2470609C (en) 2010-09-28
ES2315416T3 (es) 2009-04-01
EP1464331A1 (de) 2004-10-06
NO20042630L (no) 2004-08-13
EP1464331B9 (de) 2009-10-14
US7217429B2 (en) 2007-05-15
KR100877649B1 (ko) 2009-01-12
NZ533886A (en) 2005-12-23

Similar Documents

Publication Publication Date Title
ATE275396T1 (de) Aus mehreren einzeleinheiten zusammengesetztes pharmazeutisches präparat, das einen protonenpumpeninhibitor enthält
ATE410149T1 (de) Komprimierte, orale pharmazeutische dosierungsform mit enterischer beschichtung, die eine säurelabile benzimidazolverbindung enthält
SE9600070D0 (sv) New oral pharmaceutical dosage forms
DE69636104D1 (de) Orale pharmazeutische Zusammensetzung mit verzögerter Wirkstofffreigabe von Protonenpumpen-Hemmern
DE60029712D1 (de) Feste oral anzuwendende Arzneizubereitung mit gesteuerter Wirkstoffabgabe enthaltend eine säureempfindliche Benzimidazolverbindung
MX9604354A (es) Nueva forma de dosis farmaceutica oral.
SE9600071D0 (sv) New oral formulation of two active ingredients I
CA2214033A1 (en) Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent
EE04800B1 (et) Oraalne manustamisvorm happes ebapüsiva toimeainetarbeks, toimeaineühik, selle valmistamismeetod ja kasutamine ning meetod oraalse manustamisvormi valmistamiseks
ATE241357T1 (de) Säurelabile omeprazol enthaltende pharmazeutische zusammensetzung und verfahren zu dessen herstellung
MA25567A1 (fr) Nouvelle composition et son utilisation
DE69909316D1 (de) Pharmazeutische formulierung mit omeprazol
DE60225481D1 (de) Pharmazeutische Formulierungen mit kontrollierter Wirkstoff-Freigabe enthaltend Milchsäure-Polymer und Hydroxynaphthalin-Carbonsäure, sowie deren Herstellung
SE9700885D0 (sv) New pharmaceutical formulation
JO1881B1 (en) Formula II for multi unit disc calibration
UY27345A1 (es) Formulación farmacéutica.
UY27017A1 (es) Composiciones hidrolíticamente inestables

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1464331

Country of ref document: EP